Aquinox Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AQXP and buy or sell other stocks, options, and ETFs commission-free!About AQXP
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in January 2018 and is headquartered in New York, NY.
CEORachel L. McMinn, PhD
CEORachel L. McMinn, PhD
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2018
Founded2018
Employees—
Employees—
AQXP Key Statistics
Market cap405.90M
Market cap405.90M
Price-Earnings ratio-16.53
Price-Earnings ratio-16.53
Dividend yield—
Dividend yield—
Average volume102.49K
Average volume102.49K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$53.00
52 Week high$53.00
52 Week low$12.20
52 Week low$12.20